MR 4.5
Showing 1901 - 1925 of >10,000
Chronic Myeloid Leukemia, BCR/ABL-Positive Trial in Taipei
Not yet recruiting
- Chronic Myeloid Leukemia, BCR/ABL-Positive
-
Taipei, TaiwanNational Taiwan University Hospital
Jul 24, 2022
Tibial Fractures, Anterior Knee Pain Syndrome Trial in Canada, Spain (Infrapatellar Approach, Suprapatellar Approach)
Active, not recruiting
- Tibial Fractures
- Anterior Knee Pain Syndrome
- Infrapatellar Approach
- Suprapatellar Approach
-
Edmonton, Alberta, Canada
- +5 more
Jun 20, 2022
Sarcoma, Thoracic Cancer, Abdominal Cancer Trial in Saint Louis (Stereotactic body radiotherapy, Research blood draw)
Active, not recruiting
- Sarcoma
- +3 more
- Stereotactic body radiotherapy
- Research blood draw
-
Saint Louis, MissouriWashington University School of Medicine
Oct 17, 2022
Childhood Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan
Active, not recruiting
- Childhood Solid Neoplasm
- +4 more
- Irinotecan Hydrochloride
- +4 more
-
Birmingham, Alabama
- +20 more
Feb 1, 2023
Paroxysmal Supraventricular Tachycardia Trial in Worldwide (Etripamil NS)
Active, not recruiting
- Paroxysmal Supraventricular Tachycardia
- Etripamil NS
-
Gilbert, Arizona
- +123 more
Nov 21, 2022
Leber's Hereditary Optic Neuropathy Trial in Miami (injection of scAAV2-P1ND4v2 1.18x10e9 vg (Low),, injection of scAAV2-P1ND4v2
Active, not recruiting
- Leber's Hereditary Optic Neuropathy
- injection of scAAV2-P1ND4v2 1.18x10e9 vg (Low),
- +3 more
-
Miami, FloridaBascom Palmer Eye Institute, University of Miami
Jul 1, 2021
Prostate Cancer Trial in Canada (GTI-2040, docetaxel, prednisone)
Completed
- Prostate Cancer
- GTI-2040
- +2 more
-
Vancouver, British Columbia, Canada
- +4 more
Apr 23, 2021
Multiple Ground Glass Opacities (GGOs) Trial in Canada, United States
Recruiting
- Multiple Ground Glass Opacities (GGOs)
-
San Diego, California
- +31 more
Jan 31, 2023
Type 2 Diabetes Trial in Exeter (Sitagliptin - DPP4i, Canagliflozin - SGLT2i, Pioglitazone - TZD)
Completed
- Type 2 Diabetes
- Sitagliptin - DPP4i
- +2 more
-
Exeter, United KingdomExeter Clinical Research Facility
Mar 30, 2021
Dry Eye Trial in Nashville (nanomicellular cyclosporine 0.09%, Lifitegrast)
Recruiting
- Dry Eye
- nanomicellular cyclosporine 0.09%
- Lifitegrast
-
Nashville, TennesseeToyos Clinic
Oct 4, 2021
Standardized Invasive Hemodynamics for Elevated Gradients Post
Recruiting
- Aortic Stenosis
- Aortic Valve Stenosis
- Standardized Invasive Hemodynamics
-
Tucson, Arizona
- +10 more
Aug 30, 2022
Intra Organ Sodium Levels by Magnetic Resonance Imaging
Completed
- Image, Body
- Sodium Disorder
- MRI examination
-
Aarhus N, DenmarkMR Research Centre
Mar 17, 2022
Brain Substrates in Adults With Obesity
Completed
- Anhedonia
- Obesity
-
Mississauga, Ontario, CanadaCanadian Rapid Treatment Centre of Excellence
Jul 27, 2021
HIV Trial in Canada, United States (CAB LA, RPV LA, RPV)
Active, not recruiting
- HIV Infections
- CAB LA
- +3 more
-
Phoenix, Arizona
- +29 more
Jan 22, 2023
Nicotine Dependence, Nicotine Dependence, Cigarettes, Tobacco Use Trial in Overland Park (Virginia Tobacco flavored JUUL 5%
Completed
- Nicotine Dependence
- +3 more
- Virginia Tobacco flavored JUUL 5% ENDS
- +6 more
-
Overland Park, KansasVince & Associates Clinical Research
Jun 10, 2021
Amyotrophic Lateral Sclerosis Associated With a SOD1 Gene Mutation Trial in Worldwide (BIIB067 (Tofersen), Placebo)
Recruiting
- Amyotrophic Lateral Sclerosis Associated With a SOD1 Gene Mutation
- BIIB067 (Tofersen)
- Placebo
-
Scottsdale, Arizona
- +28 more
Oct 27, 2022
Nocturnal Enuresis Trial in United Kingdom (DryNites Pyjama Pants)
Recruiting
- Nocturnal Enuresis
- DryNites Pyjama Pants
-
Aalborg, Connor Downs, United Kingdom
- +5 more
Apr 1, 2022
Pancreatic Cancer Trial in Beijing (68Ga-FAPI-FS PET/CT)
Recruiting
- Pancreatic Cancer
- 68Ga-FAPI-FS PET/CT
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
May 16, 2023
The Designer D-dimer Deep Vein Thrombosis Diagnosis (4D) Study
Completed
- Suspected Deep Vein Thrombosis
-
Edmonton, Alberta, Canada
- +9 more
Sep 27, 2021
PRETEXT Stage 1 Hepatoblastoma, PRETEXT Stage 2 Hepatoblastoma, PRETEXT Stage 3 Hepatoblastoma Trial in Worldwide (drug, other,
Active, not recruiting
- PRETEXT Stage 1 Hepatoblastoma
- +3 more
- Cisplatin
- +9 more
-
Birmingham, Alabama
- +208 more
Jan 25, 2023
Leukemia, Myelodysplastic Syndrome, Recurrent Myelodysplastic Syndrome Trial in Houston (drug, biological, other)
Recruiting
- Leukemia
- +2 more
- Azacitidine
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jan 13, 2021
NSCLC Trial in Worldwide (Nivolumab)
Completed
- Non-Small Cell Lung Cancer
-
Wels, Oberösterreich, Austria
- +89 more
Oct 17, 2022